Terms: = Lung cancer AND ABL1, p150, 25, ENSG00000097007, P00519, v-abl, bcr/abl, JTK7, c-ABL, ABL, BCR-ABL
22331 results:
1. Efficacy and safety of neoadjuvant therapy in gastroenteropancreatic neuroendocrine neoplasms: A systematic review and meta-analysis.
Yan Y; Wu D; Wang W; Lv Y; Yang L; Liu Y; Dong P; Yu X
J Cancer Res Ther; 2024 Apr; 20(2):633-641. PubMed ID: 38687934
[TBL] [Abstract] [Full Text] [Related]
2. Application of 18F-FDG PET/CT imaging radiomics in the differential diagnosis of single-nodule pulmonary metastases and second primary lung cancer in patients with colorectal cancer.
Yu Y; Zhu J; Sang S; Yang Y; Zhang B; Deng S
J Cancer Res Ther; 2024 Apr; 20(2):599-607. PubMed ID: 38687930
[TBL] [Abstract] [Full Text] [Related]
3. Exploring new frontiers: cell surface vimentin as an emerging marker for circulating tumor cells and a promising therapeutic target in advanced gastric cancer.
Li H; Zhu YZ; Xu L; Han T; Luan J; Li X; Liu Y; Wang Z; Liu Q; Kong X; Zou C; Su L; Hou Y; Chen X; Chen L; Wang R; Xu Z; Zhao M
J Exp Clin Cancer Res; 2024 Apr; 43(1):129. PubMed ID: 38685125
[TBL] [Abstract] [Full Text] [Related]
4. Treatment strategies for stage IA non-small cell lung cancer: A SEER-based population study.
Wu B; Zhang X; Feng N; Hu Z; Wu J; Zhou W; Wei Y; Zhang W; Wang K
PLoS One; 2024; 19(4):e0298470. PubMed ID: 38683794
[TBL] [Abstract] [Full Text] [Related]
5. Demographical and Epidemiological Contribution to cancer Incidence in Delhi and Its Trends from 1991-2015.
Malhotra RK; Manoharan N; Deo SS; Bhatnagar S
Asian Pac J Cancer Prev; 2024 Apr; 25(4):1213-1222. PubMed ID: 38679980
[TBL] [Abstract] [Full Text] [Related]
6. Safety and Efficacy of Moderate-Intensity Stereotactic Body Radiation Therapy for Ultra-Central lung Tumor.
Rim CH; Yoon WS; Park S
Medicina (Kaunas); 2024 Mar; 60(4):. PubMed ID: 38674184
[No Abstract] [Full Text] [Related]
7. Asbestos ban policies and mesothelioma mortality in Greece.
Gogou E; Hatzoglou C; Siachpazidou D; Zarogiannis SG; Gourgoulianis KI
BMC Public Health; 2024 Apr; 24(1):1177. PubMed ID: 38671450
[TBL] [Abstract] [Full Text] [Related]
8. The Evaluation and Management of lung Metastases in Patients with Giant Cell Tumors of Bone in the Denosumab Era.
Trovarelli G; Rizzo A; Cerchiaro M; Pala E; Angelini A; Ruggieri P
Curr Oncol; 2024 Apr; 31(4):2158-2171. PubMed ID: 38668063
[TBL] [Abstract] [Full Text] [Related]
9. Prognostic implications of combining EGFR-TKIs and radiotherapy in Stage IV lung adenocarcinoma with 19-Del or 21-L858R mutations: A real-world study.
Liang S; Wang H; Zhang Y; Tian H; Li C; Hua D
Cancer Med; 2024 Apr; 13(8):e7208. PubMed ID: 38659399
[TBL] [Abstract] [Full Text] [Related]
10. Impact of Anti-angiogenic Drugs on Severity of COVID-19 in Patients with Non-Small Cell lung cancer.
Peng S; Huang H; Chen J; Ding X; Zhu X; Liu Y; Chen L; Lu Z
Technol Cancer Res Treat; 2024; 23():15330338241248573. PubMed ID: 38656242
[No Abstract] [Full Text] [Related]
11. 25-hydroxycholesterol promotes proliferation and metastasis of lung adenocarcinoma cells by regulating ERβ/TNFRSF17 axis.
He M; Jiang W; Li X; Liu H; Ren H; Lin Y
BMC Cancer; 2024 Apr; 24(1):505. PubMed ID: 38649856
[TBL] [Abstract] [Full Text] [Related]
12. Discovery of gefitinib-1,2,3-triazole derivatives against lung cancer via inducing apoptosis and inhibiting the colony formation.
Gao E; Wang Y; Fan GL; Xu G; Wu ZY; Liu ZJ; Liu JC; Mao LF; Hou X; Li S
Sci Rep; 2024 Apr; 14(1):9223. PubMed ID: 38649732
[TBL] [Abstract] [Full Text] [Related]
13. Efficacy and safety of neoadjuvant immunotherapy plus chemotherapy followed by adjuvant immunotherapy in resectable non-small cell lung cancer: a meta-analysis of phase 3 clinical trials.
Zhang W; Liang Z; Zhao Y; Li Y; Chen T; Li W; Chen Y; Wu P; Zhang H; Fang C; Li L
Front Immunol; 2024; 15():1359302. PubMed ID: 38646542
[TBL] [Abstract] [Full Text] [Related]
14. [cancer survival analysis in Tianjin, 2010 to 2016].
Wang C; Shen CF; Xun LN; Zhang S; Zhang H; Zheng WL; Wang DZ
Zhonghua Zhong Liu Za Zhi; 2024 Apr; 46(4):319-325. PubMed ID: 38644267
[No Abstract] [Full Text] [Related]
15. Saliva‑microbiome‑derived signatures: expected to become a potential biomarker for pulmonary nodules (MCEPN-1).
Ren Y; Ma Q; Zeng X; Huang C; Tan S; Fu X; Zheng C; You F; Li X
BMC Microbiol; 2024 Apr; 24(1):132. PubMed ID: 38643115
[TBL] [Abstract] [Full Text] [Related]
16. Phase 1a dose escalation study of ivonescimab (AK112/SMT112), an anti-PD-1/VEGF-A bispecific antibody, in patients with advanced solid tumors.
Frentzas S; Austria Mislang AR; Lemech C; Nagrial A; Underhill C; Wang W; Wang ZM; Li B; Xia Y; Coward JIG
J Immunother Cancer; 2024 Apr; 12(4):. PubMed ID: 38642937
[TBL] [Abstract] [Full Text] [Related]
17. Effect of the STK11 mutation on therapeutic efficacy and prognosis in patients with non-small cell lung cancer: a comprehensive study based on meta-analyses and bioinformatics analyses.
Xu K; Lu W; Yu A; Wu H; He J
BMC Cancer; 2024 Apr; 24(1):491. PubMed ID: 38632512
[TBL] [Abstract] [Full Text] [Related]
18. Uncertainty among patients with advanced-stage lung cancer.
Wongkalasin K; Matchim Y; Kanhasing R; Pimvichai S
Int J Palliat Nurs; 2024 Apr; 30(4):160-169. PubMed ID: 38630643
[TBL] [Abstract] [Full Text] [Related]
19. Extrapleural pneumonectomy for sarcoma: Outcomes of adult patients at a specialized center.
Zhang BY; Wilson-Smith AR; Connolly EA; Strach MC; Ussher N; Yan T; Bhadri VA
Cancer Rep (Hoboken); 2024 Apr; 7(4):e2065. PubMed ID: 38627902
[TBL] [Abstract] [Full Text] [Related]
20. Clinical and Imaging Characteristics of SARS-CoV-2 Breakthrough Infection in Hospitalized Immunocompromised Patients.
Lee JE; Kim J; Hwang M; Kim YH; Chung MJ; Jeong WG; Jeong YJ
Korean J Radiol; 2024 May; 25(5):481-492. PubMed ID: 38627873
[TBL] [Abstract] [Full Text] [Related]
[Next]
